Immunomic Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
15010 Broschart Rd Ste 250, Rockville, M...Phone Number
(301) 968-3501Website
www.immunomix.comRevenue
$5.3 MillionIndustry
About Immunomic Therapeutics
Immunomic Therapeutics, Inc. is a privately-held clinical stage biotechnology company focused on pioneering nucleic acid immunotherapy platforms, particularly through its proprietary UNiversal Intracellular Targeted Expression (UNITE) technology. The company aims to develop immune-based therapies for oncology, allergies, and animal health, leveraging its innovative approach to create vaccines that elicit broad immune responses. Its pipeline includes investigational products targeting various cancers, including glioblastoma multiforme and Merkel cell carcinoma, currently in different phases of clinical trials. Immunomic Therapeutics is dedicated to improving patient health and extending lives through advanced immunotherapy solutions.Explore more
Immunomic Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Immunomic Therapeutics
Compare insights from companies similar to Immunomic Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Immunomic Therapeutics Tech Stack
A closer look at the technologies used by Immunomic Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Immunomic Therapeutics
Sign Up For FreeTo access detailed company insights
Immunomic Therapeutics, Inc. is a privately-held clinical stage biotechnology company focused on pioneering nucleic acid immunotherapy platforms, particularly through its proprietary UNiversal Intracellular Targeted Expression (UNITE) technology. The company aims to develop immune-based therapies for oncology, allergies, and animal health, leveragi... Read More
